EPI Update, July 20, 2007 by unknown
EPI Update for Friday, July 20, 2007 
Center for Acute Disease Epidemiology 
Iowa Department of Public Health (IDPH) 
  
  
Items for this week’s EPI Update include: 
  
• Chili recalled due to possible Clostridium botulinum contamination  
• Extensively drug resistant tuberculosis (XDR TB)  
• University Hygienic Laboratory announces new director  
• Epidemic Intelligence Service Application Deadline — Sept. 15  
• Tick update  
• Meeting announcements and training opportunities  
  
Chili recalled due to possible Clostridium botulinum contamination 
Public health officials in Indiana and Texas, and the Centers for Disease Control 
and Prevention (CDC) are investigating an outbreak of botulism possibly 
associated with commercially-canned hot dog chili sauce. As of July 18, four 
cases of botulism have been reported to CDC from Indiana (2) and Texas (2). 
There are no known cases in Iowa so far. Food-borne botulism is a rare but 
serious paralytic illness caused by consuming foods that contain botulinum toxin, 
a nerve toxin produced by Clostridium botulinum.  
CDC and the Food and Drug Administration are advising persons not to eat 10-
ounce cans of Castleberry’s Hot Dog Chili Sauce (UPC 3030000101), Austex Hot 
Dog Chili Sauce (UPC 3030099533), and Kroger Hot Dog Chili Sauce (UPC 
1111083942) with “best by” dates from April 30, 2009 through May 22, 2009.  
For more information, visit www.cdc.gov/botulism/botulism.htm. 
Extensively drug resistant tuberculosis (XDR TB) 
There has been significant media coverage of XDR TB. Many people were 
surprised, thinking that TB was a thing of the past. This attention has fueled 
misconceptions about this complicated disease. Despite TB rates declining 
significantly in the U.S. since 1993, TB remains a major public health concern. 
  
Drug susceptible (regular) TB, multiple drug resistant TB (MDR TB) and XDR TB 
are all spread in the same way – via the air when infectious persons cough, 
sneeze, speak or sing, and usually only after prolonged exposure. XDR TB is a 
relatively rare type of MDR TB. Both are resistant to the two most effective first-
line drugs: isoniazid and rifampin. In addition, XDR TB is also resistant to the 
most effective second-line medications, fluoroquinolones, and at least one of 
three injectable drugs (e.g., amikacin, kanamycin, or capreomycin), thus making 
treatment very difficult.  
  
XDR TB is an emerging threat to global public health. In the United States, 48 
cases of XDR TB have been reported between 1993 and 2007. The 48 XDR-TB 
cases were reported from nine states, with the largest numbers in New York City 
(16 cases) and California (11 cases). No cases of XDR TB have been reported in 
Iowa. 
  
The World Health Organization (WHO) estimates that there were almost half a 
million cases of MDR-TB worldwide in 2004.  MDR-TB usually has to occur 
before XDR-TB arises. Wherever second-line drugs to treat MDR-TB are being 
misused, the possibility of XDR-TB exists. Research is being carried to learn 
more about XDR TB. 
  
For more information visit: 
www.cdc.gov/tb/XDRTB/default.htm
  
www.who.int/tb/xdr/faqs/en/index.html
  
www.idph.state.ia.us/adper/tb_control.asp
  
University Hygienic Laboratory announces new director 
University of Iowa (UI) Vice President for Research, Meredith Hay this week 
announced the appointment of Christopher G. Atchison as director of the 
University Hygienic Laboratory (UHL), effective Aug. 1. Atchison has served as 
interim director at the UHL since October 2006. 
  
Atchison is associate dean for public health practice and a clinical professor of 
health management and policy in the UI College of Public Health. He directs the 
college's Upper Midwest Center for Public Health Preparedness. He also chairs 
the University of Iowa Pandemic Influenza Preparedness Task Force. Prior to 
joining the UI faculty in 1999, Atchison served as director of the Iowa Department 
of Public Health from 1991 through 1998. 
  
Epidemic Intelligence Service Application Deadline — Sept. 15   
The Epidemic Intelligence Service (EIS) is a 2-year, postgraduate program of 
service and on-the-job training for health professionals interested in the practice 
of epidemiology. Former EIS Officers are working around the state of Iowa, at the 
state health department, UI Hospitals and Clinics and at the UI School of Public 
Health. 
  
Application information and EIS Program details are available at 
www.cdc.gov/eis or by e-mail at eisepo@cdc.gov. The EIS Program telephone 
number is 404-498-6110. 
  
  
Tick update 
The Medical Entomology Laboratory at Iowa State University has recently 
produced a pamphlet entitled “Ticks and Tick-borne Disease of Iowa.”    
  
This publication helps Iowans understand what types of ticks and tick-transmitted 
diseases are in Iowa. It offers information (including images and distribution 
maps) on the three most common ticks found in Iowa, the time of year they are 
active, and the types of disease agents those ticks can transmit to humans and 
animals, with emphasis on Lyme disease. It also offers advice on how to avoid 
getting a tick bite and how to effectively remove a tick, if one should attach itself 
to you or your pet. 
  
For more information visit: 
www.extension.iastate.edu/store/ItemDetail.aspx?ProductID=12612&SeriesCode
=&CategoryID=&Keyword=2036
  
Meeting announcements and training opportunities 
None. 
  
Have a healthy and happy week! And keep cool! 
Center for Acute Disease Epidemiology 
Iowa Department of Public Health 
800-362-2736 
 
